Sonova stock eases after EON launch and FY 2025/ 26 results
Published on 08/28/2026 at 09:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sonova Holding AG (CH0012549785) is trading with fresh product and results context after Phonak launched the EON hearing aid portfolio on August 24, 2026, while a recent OTC quote showed $59.86 on August 26, 2026 with a 2.01 percent daily decline.
The Swiss hearing-care group also framed the move against its latest financial year, with the company listing full-year 2025/26 results in its investor section and reiterating its current outlook for fiscal 2026/27 in the half-year materials cited by recent market coverage.
EON adds an AI angle
Sonova's own investor page says the new Phonak Audéo EON range includes EON Sphere, EON R and CROS EON R, and positions the platform around HYPERSONIC chip technology and AutoSense OS AI 8.0. That gives the launch a clear product tie-in rather than a pure branding update.
The same company page also shows a run of dated corporate events: the AGM on June 16, 2026, the EON launch on August 24, 2026 and conference appearances scheduled for September 10, 2026, September 15, 2026 and September 22, 2026.
What the latest figures say
Recent market coverage cited the half-year 2026 release as showing revenue for the six months ended June 30, 2026 that was higher than in the prior-year half, while earnings rose more slowly as investments and cost inflation weighed on margins.
That same coverage said management kept guidance for the fiscal year ending March 31, 2027, with revenue growth expected in the mid-single to high-single-digit percentage range and earnings growth in a similar corridor.
For investors, the comparison matters: revenue growth in the latest half-year was stronger than earnings growth, and the guidance still points to another growth year rather than a reset.
Hearing aid portfolio
Phonak EON is the representative product line to watch because it is the hardware side of the current story. The launch centers on speech clarity, scene intelligence and Made-For-All connectivity, which keeps Sonova's hearing-care franchise tied to premium device upgrades.
Sonova stock last traded at $59.86 on August 26, 2026, and that quote sat alongside a 2.01 percent daily decline in the same snapshot.
Price and setup
The OTC line gives US investors a dated reference point, while the Swiss listing remains the main home-market instrument for the company. Sonova Holding AG continues to sit in the healthcare-medical devices segment, with the investor page placing full-year 2025/26 results and upcoming September conferences in the foreground.
Fact box
Company: Sonova Holding AG
ISIN: CH0012549785
Ticker: SONN
Exchange: SIX Swiss Exchange; SONVY OTC depositary line
Price (as of August 26, 2026, 3:39 p.m. ET): $59.86 USD
Market cap: multi-billion CHF range
Sector / Industry: Healthcare / Medical devices
Index membership: Swiss equity indices
Next earnings date: September 10, 2026
